FDA Approves Cohero Health’s Mobile Spirometer to Measure Critical Lung Function

Cohero Health, a company focused on developing connected health tools and technologies to improve respiratory care, has received the FDA clearance for its mobile spirometer.

According to the developer, the handheld, wireless spirometer measures critical lung function metrics with the same precision as clinical-grade spirometers.

Clinical Trials and Its different Phases
Clinical trials serve as a vital component for improving the treatment of medical conditions as they lead to higher standards of patient care.

The mobile spirometer pairs with a smartphone or tablet, enabling real-time measurement and reporting.

The device integrates with Cohero Health’s mobile asthma and Chronic obstructive pulmonary disease (COPD) management platform. The device includes bluetooth sensors that attach to maintenance and rescue medication and mobile apps that track medication usage, motivate, remind, and reward patients for improved adherence to prescribed medication.

Cohero Health Co-founder and CEO Melissa Manice, PhD, MPH, said, "We are enhancing respiratory care by recording critical measurements over time outside of a physician’s office. This longitudinal view of changes in lung function over time, in parallel with medication adherence tracking, equips physicians to partner with their patient to make more informed treatment decisions together. We’re really excited to be leading a new era of collaborative data driven clinical decisions."

World's First Female Viagra: FDA Panel Backs Flibanserin With Safety Restriction
The pink pill, taken once a day at bedtime, would be approved for pre-menopausal women suffering a lack of sexual desire that causes them distress.

The Cohero Health platform has been deployed in closed pilots in healthcare systems. Early results have shown a 2.5 times increase in medication adherence, and 100% reduction in hospitalizations. The company is expanding to additional pilots ahead of full commercial launch of their full platform later this year.

“The inclusion of a mobile spirometer in our platform allows stakeholders to track, for the first time ever, how patients are using their medication, and how they are responding to their medication, in real-time. Through robust tracking, motivating better behaviors, and early identification of potential acute events, the Cohero Health platform enables better patient management, reduced costs to the healthcare system, and most importantly, healthier patients,” said Cohero Health Co-founder and COO, Daniel Weinstein.

Carestream�s Touch Prime Ultrasound and Touch Prime XE Ultrasound Secure FDA Approval
Carestream’s Ultrasound Systems’ high-level computing power provides both speed and excellent image quality and a sealed panel allows for easy cleaning.

Source-Medindia

FDA Approves Cipla�s Drug Delivery System for Infants and Children Suffering from HIV
Oral pellets are preferred antiretroviral in pediatric patents and this drug delivery system is a breakthrough in pediatric-specific treatment for infants.